Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/1672 stock hub

HKG/1672 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/1672is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

18B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/1672

In the news

Latest news · HKG/1672

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E33.7

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROE-18.5

P25 -14.7P50 2P75 9.4

ROIC-15.5

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/1672 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

161

Groups with data

Currency

CNY

Showing 161 of 161 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	208
Enterprise value	HKD 15.9B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	KYG0520K1094
Last refreshed	2026-05-10
Market cap	HKD 18B
Price	HKD 16.94
Price currency	HKD
Rev Per Employee	11,172.17x
Sector	Healthcare
Sic	2836
Symbol	hkg/1672
Website	https://www.ascletis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.23%
EV Earnings	-39.61x
Forward P/E	33.65x
P/B ratio	8.35x
P/S ratio	7,965.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	25.99%
Gross Profit	HKD 586,451
Gross Profit Growth	-38.43%
Gross Profit Growth Q	-44.76%
Net Income	HKD -400.5M
Net Income Growth Years	0%
Pretax Margin	-17,720.61%
Profit Per Employee	HKD -2M
ROA	-14.45
Roa5y	-9.15
ROCE	-24.99
ROE	-18.45
Roe5y	-11.45
ROIC	-15.48

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	167.8%
Cagr3y	82.63%
Cagr5y	39.65%
EPS Growth Years	0
Revenue Growth	58.07x
Revenue Growth Q	-26.19x
Revenue Growth Years	1x
Revenue Growth3 Y	-41.42x
Revenue Growth5 Y	-49.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0
Assets	HKD 2.3B
Cash	HKD 2.1B
Current Assets	HKD 2.2B
Current Liabilities	HKD 146.9M
Debt	HKD 5.7M
Debt Equity	HKD 0
Equity	HKD 2.2B
Interest Coverage	-2,954.5
Liabilities	HKD 147.2M
Long Term Assets	HKD 87.8M
Long Term Liabilities	HKD 251,163
Net Cash	HKD 2.1B
Net Cash By Market Cap	HKD 11.75
Net Cash Growth	-2.37%
Net Debt Equity	HKD -0.98
Tangible Book Value	HKD 2.1B
Tangible Book Value Per Share	HKD 2.16
WACC	6.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	15.05
Inventory Turnover	0.48
Net Working Capital	HKD -120.1M
Quick ratio	15
Working Capital	HKD 2B
Working Capital Turnover	HKD 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.9%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	167.62%
200-day SMA	13.5
3Y total return	509.35%
50-day SMA	16.28
50-day SMA vs 200-day SMA	50over200
5Y total return	431.03%
All Time High	19.86
All Time High Change	-14.7%
All Time High Date	2026-04-20
All Time Low	0.76
All Time Low Change	2,128.95%
All Time Low Date	2024-08-23
ATR	1.04
Beta	0.47
Beta1y	1.54
Beta2y	0.45
Ch YTD	48.73
High	17.2
High52	19.86
High52 Date	2026-04-20
High52ch	-14.7%
Low	16.69
Low52	5.3
Low52 Date	2025-05-19
Low52ch	219.62%
Ma50ch	4.03%
Price vs 200-day SMA	25.44%
RSI	49.6
RSI Monthly	70.09
RSI Weekly	57.2
Sharpe ratio	1.44x
Sortino ratio	2.3
Total Return	2.9%
Tr YTD	48.73
Tr1m	-0.24%
Tr1w	0.24%
Tr3m	11.45%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -539.2M
Operating margin	-23,892.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	244,592,081%
Shares Insiders	51.61%
Shares Institutions	4.06%
Shares Out	1,061,130,320
Shares Qo Q	2.08%
Shares Yo Y	-2.9%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,830,906.8x
Bv Per Share	2.17
Ch1m	-0.24
Ch1w	0.24
Ch1y	167.6
Ch3m	11.45
Ch3y	509.4
Ch5y	431
Ch6m	79.26
Change	0.24%
Change From Open	1.5
Close	16.9
Days Gap	-1.24
Depreciation Amortization	14,837,889.9
Dollar Volume	10,257,695.1
Earnings Date	2026-08-14
EBIT	HKD -539.2M
EBITDA	HKD -524.9M
EPS	HKD -0.41
F Score	1
Financing CF	384,171,031
Fiscal Year End	December
Founded	2,013
Income Tax	HKD 563,082
Investing CF	736,879,577
Is Primary Listing	1
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Ma150	13.79
Ma150ch	22.82%
Ma20	17.56
Ma20ch	-3.53%
Net CF	644,525,229
Next Earnings Date	2026-08-14
Open	16.69
Position In Range	49.02
Ppne	53,780,297.6
Price Date	2026-05-08
Ptbv Ratio	8.4
Relative Volume	0.33x
Revenue	2,256,779x
Tax By Revenue	24.95x
Tr6m	79.26%
Volume	605,531

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/1672 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/1672 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/1672?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.1%

Share of float held by funds and institutions

Insider ownership

+51.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.9%

Negative means the company is buying back shares.

Technical

HKG/1672 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.6

Neutral momentum band

Price vs 200-day MA

+25.4%

50/200-day relationship not available

Beta (5Y)

0.47

Less volatile than the market

Sharpe ratio

1.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/1672

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/1672 stock rating?

hkg/1672 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/1672 analysis?

The full report lives at /stocks/hkg/1672/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/1672?

The latest report frames hkg/1672 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/1672 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.